These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Reliability of isometric lower-extremity muscle strength measurements in children with cerebral palsy: implications for measurement design. Willemse L; Brehm MA; Scholtes VA; Jansen L; Woudenberg-Vos H; Dallmeijer AJ Phys Ther; 2013 Jul; 93(7):935-41. PubMed ID: 23538586 [TBL] [Abstract][Full Text] [Related]
44. The reliability and validity of handheld dynamometry for the measurement of lower-extremity muscle strength in older adults. Arnold CM; Warkentin KD; Chilibeck PD; Magnus CR J Strength Cond Res; 2010 Mar; 24(3):815-24. PubMed ID: 19661831 [TBL] [Abstract][Full Text] [Related]
45. Clinical and genetic study of spinal muscular atrophies in Oman. Koul R; Al Futaisi A; Chacko A; Rao V; Simsek M; Muralitharan S; Ganguly SS; Bayoumi R J Child Neurol; 2007 Oct; 22(10):1227-30. PubMed ID: 17940251 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of muscle strength in patients with spinal muscular atrophy. Wang HY; Yang YH; Jong YJ Kaohsiung J Med Sci; 2002 May; 18(5):241-7. PubMed ID: 12197431 [TBL] [Abstract][Full Text] [Related]
49. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy. Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293 [TBL] [Abstract][Full Text] [Related]
50. Prospective analysis of strength in spinal muscular atrophy. DCN/Spinal Muscular Atrophy Group. Iannaccone ST; Russman BS; Browne RH; Buncher CR; White M; Samaha FJ J Child Neurol; 2000 Feb; 15(2):97-101. PubMed ID: 10695894 [TBL] [Abstract][Full Text] [Related]
51. [Analysis of survival motor neuron gene conversion in patients with spinal muscular atrophy]. He SX; Ge XS; Qu YJ; Jin YW; Wang H; Bai JL; Song F Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Dec; 28(6):606-11. PubMed ID: 22161088 [TBL] [Abstract][Full Text] [Related]
52. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy. Vezain M; Saugier-Veber P; Melki J; Toutain A; Bieth E; Husson M; Pedespan JM; Viollet L; Pénisson-Besnier I; Fehrenbach S; Bou J; Frébourg T; Tosi M Eur J Hum Genet; 2007 Oct; 15(10):1054-62. PubMed ID: 17609673 [TBL] [Abstract][Full Text] [Related]
53. Spontaneous motor unit firing in spinal muscular atrophy of childhood. Hausmanowa-Petrusewicz I; Friedman A; Kowalski J; Skalski M Electromyogr Clin Neurophysiol; 1987; 27(5):259-64. PubMed ID: 3665810 [No Abstract] [Full Text] [Related]
54. Is RNA manipulation a viable therapy for spinal muscular atrophy? Horne C; Young PJ J Neurol Sci; 2009 Dec; 287(1-2):27-31. PubMed ID: 19758605 [TBL] [Abstract][Full Text] [Related]
55. An analysis of disease severity based on SMN2 copy number in adults with spinal muscular atrophy. Elsheikh B; Prior T; Zhang X; Miller R; Kolb SJ; Moore D; Bradley W; Barohn R; Bryan W; Gelinas D; Iannaccone S; Leshner R; Mendell JR; Mendoza M; Russman B; Smith S; King W; Kissel JT Muscle Nerve; 2009 Oct; 40(4):652-6. PubMed ID: 19760790 [TBL] [Abstract][Full Text] [Related]
56. Six-Minute Walk Test demonstrates motor fatigue in spinal muscular atrophy. Montes J; McDermott MP; Martens WB; Dunaway S; Glanzman AM; Riley S; Quigley J; Montgomery MJ; Sproule D; Tawil R; Chung WK; Darras BT; De Vivo DC; Kaufmann P; Finkel RS; Neurology; 2010 Mar; 74(10):833-8. PubMed ID: 20211907 [TBL] [Abstract][Full Text] [Related]
57. Investigation of the role of SMN1 and SMN2 haploinsufficiency as a risk factor for Hirayama's disease: clinical, neurophysiological and genetic characteristics in a Spanish series of 13 patients. Gamez J; Also E; Alias L; Corbera-Bellalta M; Barceló MJ; Centeno M; Raguer N; Gratacós M; Baiget M; Tizzano EF Clin Neurol Neurosurg; 2007 Dec; 109(10):844-8. PubMed ID: 17850955 [TBL] [Abstract][Full Text] [Related]
59. Association of motor milestones, SMN2 copy and outcome in spinal muscular atrophy types 0-4. Wadman RI; Stam M; Gijzen M; Lemmink HH; Snoeck IN; Wijngaarde CA; Braun KP; Schoenmakers MA; van den Berg LH; Dooijes D; van der Pol WL J Neurol Neurosurg Psychiatry; 2017 Apr; 88(4):365-367. PubMed ID: 28108522 [No Abstract] [Full Text] [Related]
60. Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy. Watihayati MS; Fatemeh H; Marini M; Atif AB; Zahiruddin WM; Sasongko TH; Tang TH; Zabidi-Hussin ZA; Nishio H; Zilfalil BA Brain Dev; 2009 Jan; 31(1):42-5. PubMed ID: 18842367 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]